Pyxis Oncology : to Acquire Apexigen - Form 8-K
Pyxis Oncology to Acquire Apexigen Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate development Commercially and clinically validated APXiMAB... | May 24, 2023
United States Laras Sullivan William Duke Xiaodong Yang Wilson Sonsini Goodrich Rosati Jaym Feingold
Source: marketscreener.com